A systematic review of the quality of liver biopsy specimens.

Characteristics for an optimal liver biopsy specimen were recently defined as 20 to 25 mm long and/or containing more than 11 complete portal tracts (CPTs). A systematic review of percutaneous liver biopsy (PLB) and transjugular liver biopsy (TJLB) series yielded only 32 PLB studies in which these characteristics were evaluated: mean +/- SD length, 17.7 +/- 5.8 mm and number of CPTs, 7.5 +/- 3.4; and 15 TJLB studies: mean +/- SD length, 13.5 +/- 4.5 mm and number of CPTs, 6.8 +/- 2.3. Studies of sampling heterogeneity and intraobserver and interobserver variability also used inadequate specimens by present standards. Only 11 (5.3%) of 207 therapeutic studies for chronic hepatitis B and C documented length and/or number of CPTs. Of the current 12 studies evaluating noninvasive fibrosis tests, only 8 documented length or number of CPTs, and only 1 documented length and number of CPTs. New studies are needed based on adequate liver biopsy samples to provide reliable estimation of grading and staging in chronic liver disease.

[1]  R. P. Thompson,et al.  Experience with transjugular liver biopsy. , 1983, Gut.

[2]  H. Bonkovsky,et al.  Comparative Effects of Different Doses of Ribavirin Plus Interferon-α2b for Therapy of Chronic Hepatitis C: Results of a Controlled, Randomized Trial , 2001, Digestive Diseases and Sciences.

[3]  W D Carey,et al.  The role of liver biopsy in chronic hepatitis C , 2001, Hepatology.

[4]  J H Lewis,et al.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey. , 2001, Digestive diseases and sciences.

[5]  A. Memon,et al.  Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus Infection , 2003, Scandinavian journal of gastroenterology.

[6]  S. Klauck,et al.  Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy , 2003, Virchows Archiv.

[7]  J. Puel,et al.  Better efficacy of a 12‐month interferon alfa‐2b retreatment in patients with chronic hepatitis C relapsing after a 6‐month treatment: A multicenter, controlled, randomized trial , 1998, Hepatology.

[8]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[9]  A. Andriulli,et al.  Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. , 1996, The American journal of gastroenterology.

[10]  J. Pelage,et al.  Transjugular liver biopsy with an automated device. , 1997, Radiology.

[11]  J. Goldin,et al.  Intra-observer variation in the histopathological assessment of chronic viral hepatitis , 1996 .

[12]  C. Bodian,et al.  Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  B. Maharaj,et al.  Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are taken. , 1992, Postgraduate medical journal.

[14]  F. Carnot,et al.  Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. , 2001, Human pathology.

[15]  M. Yuen,et al.  Viral hepatitis C , 2003, The Lancet.

[16]  Z. Younossi,et al.  Ultrasound-guided liver biopsy for parenchymal liver disease. An economic analysis , 1998 .

[17]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[18]  Christos Christidis,et al.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.

[19]  P. Schnyder,et al.  Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsy , 2004, European Radiology.

[20]  F. Zoulim,et al.  Longitudinal Assessment of Histology Surrogate Markers (FibroTest–ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection , 2005, The American Journal of Gastroenterology.

[21]  A. Zajko,et al.  Transjugular liver biopsy: a prospective study in 43 patients with the Quick-Core biopsy needle. , 1996, Journal of vascular and interventional radiology : JVIR.

[22]  N. Mcintyre,et al.  A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. , 1993, Journal of hepatology.

[23]  L. Vargas-Tank,et al.  Tru-cut and Menghini needles: different yield in the histological diagnosis of liver disease. , 2008, Liver.

[24]  S. Klauck,et al.  Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases. , 2001, Liver.

[25]  S. Hadziyannis,et al.  Current management of chronic hepatitis B , 2004, Alimentary pharmacology & therapeutics.

[26]  Tony P. Smith,et al.  Transjugular biopsy of the liver in pediatric and adult patients using an 18-gauge automated core biopsy needle: a retrospective review of 410 consecutive procedures. , 2003, AJR. American journal of roentgenology.

[27]  B. Ramakrishna,et al.  Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. , 2003, Journal of hepatology.

[28]  Z. Abbas,et al.  Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? , 1996, Journal of hepatology.

[29]  B. Stotland,et al.  Liver biopsy complications and routine ultrasound. , 1996, The American journal of gastroenterology.

[30]  Llorenç Quintó,et al.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model , 2002, Hepatology.

[31]  M. Campbell,et al.  Noninvasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients With Chronic Hepatitis C , 2006 .

[32]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[33]  Paul Calès,et al.  Sources of variability in histological scoring of chronic viral hepatitis , 2005, Hepatology.

[34]  T. Poynard,et al.  Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.

[35]  Randall G. Lee,et al.  Transjugular liver biopsy , 1992, Hepatology.

[36]  British Society of Gastroenterology , 1963 .

[37]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.

[38]  L. Bolondi,et al.  What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. , 1997, Journal of hepatology.

[39]  O. Harris,et al.  Transjugular liver biopsy--an Australian experience. , 1988, Australian and New Zealand journal of medicine.

[40]  T. Serrano,et al.  Efficacy of interferon for chronic hepatitis C virus–related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation , 2001, American Journal of Gastroenterology.

[41]  D. Hopwood,et al.  COMPARATIVE TRIAL OF LIVER-BIOPSY NEEDLES , 1979, The Lancet.

[42]  J Rakela,et al.  The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy , 1996, Hepatology.

[43]  V. de Lédinghen,et al.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.

[44]  K. Hopper,et al.  Blinded comparison of biopsy needles and automated devices in vitro: 1. Biopsy of diffuse hepatic disease. , 1993, AJR. American journal of roentgenology.

[45]  G. Leandro,et al.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.

[46]  A. Grant,et al.  Guidelines on the use of liver biopsy in clinical practice , 1999, Gut.

[47]  A. Demetris,et al.  Pathologist's perspective on liver needle biopsy size? , 2003, Journal of hepatology.

[48]  William M. Lee,et al.  Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort , 2005, Hepatology.

[49]  R. Little,et al.  Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long‐term methotrexate: a multicentre audit and health economic analysis , 2005, The British journal of dermatology.

[50]  P. Marcellin,et al.  Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study , 2002 .

[51]  P. Thampanitchawong,et al.  Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.

[52]  D. Trost,et al.  Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[53]  Fiedler,et al.  Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C , 1998, Histopathology.

[54]  T. Wright,et al.  A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. , 2003, Journal of hepatology.

[55]  L. Seeff,et al.  Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .

[56]  J. Crowe,et al.  Transjugular liver biopsy: assessment of safety and efficacy of the Quick-Core biopsy needle , 2002, Abdominal Imaging.

[57]  W. Irving,et al.  Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study , 2004, Gut.

[58]  R. Testa,et al.  Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. , 2003, Archives of internal medicine.

[59]  A. Tobkes,et al.  Liver biopsy: review of methodology and complications. , 1995, Digestive diseases.

[60]  S. Tong,et al.  Transjugular liver biopsy with an automated trucut-type needle: comparative study with percutaneous liver biopsy , 2002, European journal of gastroenterology & hepatology.

[61]  N. Juul,et al.  Surecut 0.6 mm liver biopsy in the diagnosis of cirrhosis. , 2008, Liver.

[62]  F. Shanahan,et al.  Tissue viral load variability in chronic hepatitis C , 2001, American Journal of Gastroenterology.

[63]  A. Andriulli,et al.  First, do not harm: power, oppression, and violence of liver biopsy , 2003 .

[64]  B J Ott,et al.  A 21-year experience with major hemorrhage after percutaneous liver biopsy. , 1990, Gastroenterology.

[65]  A P Dhillon,et al.  Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. , 1999, Liver.

[66]  B. Maharaj,et al.  SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.

[67]  H. Denk,et al.  [Is percutaneous liver biopsy using the Trucut (Travenol) needle superior to Menghini puncture?]. , 1989, Zeitschrift fur Gastroenterologie.

[68]  R. Bruno,et al.  Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. , 2004, Journal of hepatology.

[69]  M. Colombo,et al.  Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. , 1988, Gastroenterology.

[70]  G. Everson,et al.  Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics , 1999, Hepatology.

[71]  S. Hamilton-Dutoit,et al.  Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C , 2002, Journal of viral hepatitis.

[72]  M. Pirisi,et al.  Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases , 2005, Hepatology.

[73]  E. Schiff,et al.  Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. , 2003, Journal of hepatology.

[74]  G. Koukoulis.  Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome. , 2001, Human pathology.

[75]  M. Maynar,et al.  Transjugular liver biopsy: A review of 77 biopsies using a spring-propelled cutting needle (biopsy gun) , 1996, CardioVascular and Interventional Radiology.

[76]  J. Trotter,et al.  A Survey of Current Liver Biopsy Practice Patterns , 2000, Journal of clinical gastroenterology.

[77]  G Goldfarb,et al.  Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. , 1982, Gastroenterology.

[78]  P. Marcellin,et al.  Reinforced interferon alpha‐2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial , 2003, Journal of viral hepatitis.

[79]  Enrico Rossi,et al.  Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. , 2003, Clinical chemistry.

[80]  Samuel S. Lee,et al.  Indicators and predictors of response to anti‐viral therapy in chronic hepatitis C , 2003 .

[81]  G. Lucarelli,et al.  Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies , 1995, British journal of haematology.

[82]  G. Norkrans,et al.  Progression of fibrosis in untreated patients with hepatitis C virus infection. , 2002, Liver.

[83]  V. Paradis,et al.  Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.

[84]  D. Lebrec.  Various approaches to obtaining liver tissue--choosing the biopsy technique. , 1996, Journal of hepatology.

[85]  J. Hoefs,et al.  Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial , 1997 .

[86]  K. Bjøro,et al.  Effect of Interferon-α Induction Therapy on Genotype 2b/3a and Low Viral Load Hepatitis C Virus Infection: A Randomized Multicentre Study , 2002, Scandinavian journal of gastroenterology.

[87]  R. Wiesner,et al.  Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. , 2002 .

[88]  V. Wong,et al.  Identification of Chronic Hepatitis B Patients without Significant Liver Fibrosis by a Simple Noninvasive Predictive Model , 2005, The American Journal of Gastroenterology.

[89]  J. Dienstag,et al.  The role of liver biopsy in chronic hepatitis C , 2002, Hepatology.

[90]  S. Sherlock,et al.  Diseases of the Liver and Biliary System , 1955 .

[91]  F. Goldner.  Comparison of the Menghini, Klatskin and Tru‐Cut Needles in Diagnosing Cirrhosis , 1979, Journal of clinical gastroenterology.

[92]  J. Bruzzi,et al.  Liver biopsy. , 2001, The New England journal of medicine.

[93]  N. Afdhal,et al.  Evaluation of Liver Fibrosis: A Concise Review , 2004, American Journal of Gastroenterology.

[94]  Comparison of two needles, the surecut (18G) versus the “Biopty Gun” (Bard 18G) in percutaneous liver biopsy , 2000 .

[95]  Shou-Dong Lee,et al.  Transjugular liver biopsy: Comparison with percutaneous liver biopsy , 1994, Journal of gastroenterology and hepatology.

[96]  M. Manns,et al.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa‐2b and ribavirin , 2003, Hepatology.

[97]  Transjugular liver biopsy: Is it effective for accurate histological interpretation? , 2005 .

[98]  R. Levine,et al.  Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial , 2000, Hepatology.

[99]  T. Bolin.  Gastrointestinal endoscopy , 1992, The Medical journal of Australia.

[100]  M. Martínez-ríos,et al.  Transjugular Liver Biopsy in 52 Patients with an Automated Trucut-Type Needle , 2004, Digestive Diseases and Sciences.

[101]  L. Blendis,et al.  Transjugular liver biopsy: a review of 461 biopsies. , 1985, Radiology.

[102]  K. Bjøro,et al.  Effect of Combined Interferon-α Induction Therapy and Ribavirin on Chronic Hepatitis C Virus Infection: a Randomized Multicentre Study , 2002, Scandinavian journal of gastroenterology.

[103]  F. Degos,et al.  Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.

[104]  D. Schuppan,et al.  Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.

[105]  Xi-Zhang Lin,et al.  The normal adult human liver biopsy: A quantitative reference standard , 1998, Hepatology.

[106]  P. Schlichting,et al.  Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. , 1980, Scandinavian journal of gastroenterology.

[107]  N. Afdhal.  Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests? , 2003, Hepatology.

[108]  A. Alberti,et al.  Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection , 2002, Annals of Internal Medicine.

[109]  Papatheodoridis,et al.  Transjugular liver biopsy in the 1990s: a 2‐year audit , 1999, Alimentary pharmacology & therapeutics.

[110]  T. Imperiale,et al.  Endoscopic ultrasound–guided fine needle aspiration cytology of solid liver lesions: a large single-center experience , 2003, American Journal of Gastroenterology.

[111]  R. Gugler,et al.  Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection , 2004, Journal of viral hepatitis.

[112]  Dermot Kelleher,et al.  Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. , 1999, Journal of hepatology.

[113]  F. T. ten Kate,et al.  A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals , 2000, Journal of clinical pathology.

[114]  E. Schiff,et al.  Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.

[115]  P. Schlichting,et al.  Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. , 1983, Scandinavian journal of gastroenterology.

[116]  J. Izopet,et al.  Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial. , 2001, Journal of hepatology.

[117]  J. George,et al.  Fibrosis progression in chronic hepatitis C virus infection , 2004, Gut.

[118]  J. Goldin,et al.  Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. , 1996, Journal of hepatology.

[119]  E. Papini,et al.  A randomized trial of ultrasound-guided anterior subcostal liver biopsy versus the conventional Menghini technique. , 1991, Journal of hepatology.

[120]  R. Torella,et al.  Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy , 2002, American Journal of Gastroenterology.

[121]  A. Craxì,et al.  Long-term course of interferon-treated chronic hepatitis C. , 1998, Journal of hepatology.

[122]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.